You can now get up to 20 free RNS alerts every day as a registered member. Clickhere to set-up your alerts.

Less Ads, More Data, More Tools Register for FREE
Sponsored Content
Don't want ads? Click here
Sponsored Content
Don't want ads? Click here

Pin to quick picksFusion Antibodies Share Price (FAB)

Share Price Information for Fusion Antibodies (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.65
Bid: 6.50
Ask: 6.80
Change: 0.25 (3.91%)
Spread: 0.30 (4.615%)
Open: 6.40
High: 6.65
Low: 6.40
Prev. Close: 6.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Timelines are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fusion Antibodies Plc Ord 4p

Fusion Antibodies is listed in the FTSE AIM All-Share index.

Fusion Antibodies is listed in the Health Care and Related Services sector.

Fusion Antibodies Plc Ord 4p is listed on the London Stock Exchange trading with ticker code FAB.L. It has a market capitalisation of £6.38m, with approximately 95.95m shares in issue. Over the last year, Fusion Antibodies share price has been traded in a range of 7.60, hitting a high of 10.50, and a low of 2.90.

Fusion Antibodies plc, established in 2001 and headquartered in Belfast, Northern Ireland, is a contract research organisation specialising in antibody development services. They offer end-to-end solutions from antigen design to cell line development, including antibody humanization, affinity maturation, and protein engineering. Their proprietary technology platforms, such as CDRx® for antibody humanisation and RAMP® for affinity maturation, support the development of pre-clinical biologics. The company's shares have been traded on AIM since December 2017.

Fusion Antibodies Share Price
Price 6.65
Bid 6.50
Ask 6.80
Change 0.25 (3.91%)
Volume 935,118
Open 6.40
High 6.65
Low 6.40
Prev. Close 6.40
Currency GBX
Issue Country GB
Shares in Issue 95.95m
Market Capitalisation £6.38m
Market Size 30,000
52 Week High 10.50
52 Week High Date 07-Jan-2025
52 Week Low 2.90
52 Week Low Date 04-Sep-2024
# Trades 43
Vol. Sold 146,790
Sold Value £9.38k
Vol. Bought 788,328
Bought Value £51.56k
PE Ratio -1.705128
Earnings -3.90
Dividend 0.00
Yield 0.00%
Add FAB to WatchlistAdd FAB to Watchlist
What if I invested £1,000 in Fusion Antibodies?
 1 month ago3 months ago6 months ago1 year ago
Fusion Antibodies£806.06 -19.39%£1,015.27 1.53%£2,046.15 104.62%£1,705.13 70.51%
Great for
Spread Betting and CFDs
Capital at risk.
Go to site
Great for
0% commission
Other fees apply.
Capital at risk.
Go to site
Great for
Larger Investment Pots
Capital at risk.
Go to site
Great for
Low Fees
Capital at risk.
Go to site

Recent Share Trades for Fusion Antibodies (FAB)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
19-Mar-2513:25:236.788840,000Buy*6.506.802,716O Ordinary
19-Mar-2513:02:396.547,425Sell*6.506.80485.60O Ordinary
19-Mar-2512:20:306.78514,207Buy*6.506.80963.94O Ordinary
19-Mar-2512:11:426.7856Buy*6.506.800.41O Ordinary
19-Mar-2511:59:166.777714,665Buy*6.506.80993.95O Ordinary
19-Mar-2511:57:156.777711,715Buy*6.506.80794.01O Ordinary
19-Mar-2511:54:406.77777,318Buy*6.506.80495.99O Ordinary
19-Mar-2511:32:006.785219Buy*6.506.8014.86O Ordinary
19-Mar-2510:57:466.6040,000Buy*6.506.602,640O Ordinary
19-Mar-2510:55:016.6025,000Buy*6.506.601,650O Ordinary

Directors Deals for Fusion Antibodies (FAB)

Announced Traded Action Notifier Price Currency Amount Holding
16-Oct-2416-Oct-24BuyAdrian Kinkaid held the position of CEO at the time of this trade.Adrian Kinkaid4.18GBX83,728449,575
16-Oct-2415-Oct-24PlacingColin Walsh held the position of Non-Executive Director at the time of this trade.Colin Walsh4.15GBX325,30128,878,013
16-Oct-2415-Oct-24PlacingSimon Gordon Douglas held the position of Chairman at the time of this trade.Simon Gordon Douglas4.15GBX180,722999,587
09-Sep-2409-Sep-24BuyRichard John Buick held the position of Chief Scientific Officer at the time of this trade.Richard John Buick3.28GBX94,825794,825
05-Sep-2404-Sep-24BuyAdrian Kinkaid held the position of CEO at the time of this trade.Adrian Kinkaid3.17GBX120,000365,847
Fusion Antibodies

View share price, top shareholders, your shareholding, and interact with announcements for Fusion Antibodies plc.

Fusion Antibodies Home Page

Make Better Investment Decisions

Register for FREE

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.